Clinical Trials on Lymphoma, Large-Cell, Diffuse in Australia
Total 483 results
-
BioCryst PharmaceuticalsCompletedCutaneous T-cell Lymphoma (CTCL),United States, Australia, Germany, Italy, Spain, France, Austria, Finland, Switzerland, United Kingdom
-
Spectrum Pharmaceuticals, IncTerminatedPeripheral T-cell LymphomaBelgium, Spain, United States, Australia, France, Israel, Canada, United Kingdom, New Zealand, Italy, Ireland, Poland, Puerto Rico
-
Sana BiotechnologyRecruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States, Australia
-
BeiGeneCompletedMarginal Zone Lymphoma | MZLChina, Australia, Italy, France, New Zealand, Czechia, United Kingdom, United States, Korea, Republic of
-
Imugene LimitedActive, not recruitingNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Squamous Non-small-cell Lung Cancer | Large Cell Carcinoma Lung | Adenocarcinoma LungUnited States, Australia
-
Janssen Research & Development, LLCCity of Hope Medical CenterRecruitingRelapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States, Australia
-
Hoffmann-La RocheRecruitingMature B-Cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Denmark, Australia, Germany, Italy
-
St. Jude Children's Research HospitalIncyte Corporation; Amgen; ServierActive, not recruitingAcute Lymphoblastic Leukemia | Acute Lymphoblastic LymphomaUnited States, Australia
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia
-
Novartis PharmaceuticalsCompletedFollicular Lymphoma, Mantle Cell LymphomaAustria, France, United States, Germany
-
AbbVieCompletedLymphoblastic Lymphoma | Acute Lymphoblastic Leukemia (ALL)United States, Australia
-
Medical University of ViennaCompleted
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, Taiwan, Malaysia, Australia
-
Pharmacyclics LLC.CompletedChronic Lymphocytic Leukemia | Small-Cell LymphomaUnited States, Australia, Austria, Belgium, Canada, Czechia, France, Israel, Italy, New Zealand, Poland, Russian Federation, Spain, Sweden, Turkey, United Kingdom
-
Kite, A Gilead CompanyCompletedB-cell LymphomaUnited States, Australia, France
-
Janssen Research & Development, LLCMayo ClinicRecruitingRelapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States, Australia, Israel
-
Children's Cancer and Leukaemia GroupCompletedLeukemiaUnited Kingdom, Australia
-
CRISPR Therapeutics AGActive, not recruitingT Cell LymphomaUnited States, Australia, Canada
-
Therapeutic Advances in Childhood Leukemia ConsortiumRecruitingLymphoma, B-Cell | Hodgkin Lymphoma | Lymphoblastic Lymphoma | Lymphoma, T-Cell | AML | Hematologic Malignancy | MDS | Acute Undifferentiated Leukemia | ALL | Mixed Phenotype Acute Leukemia | BPDCNUnited States, Australia
-
CephalonCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaAustralia, Canada, United States
-
Eli Lilly and CompanyCompletedMantle-Cell LymphomaAustralia, France, Germany, Netherlands
-
Merck Sharp & Dohme LLCRecruitingLeukemia, Lymphocytic, Chronic, B-Cell | Lymphoma, Small Lymphocytic | CLL | SLL | Small-Cell Lymphoma | Leukemia, Chronic LymphocyticItaly, Argentina, Chile, Brazil, Israel, South Africa, United States, Australia, Puerto Rico, Spain, Canada, Germany, France, United Kingdom, Colombia
-
TG Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaAustralia, Poland
-
Peter MacCallum Cancer Centre, AustraliaCompletedMultiple Myeloma | Nodal Lymphoma | Lymphoma With Cutaneous Involvement | Lymphoma in Leukemic Phase | Marrow Involvement With LymphomaAustralia
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinCanada, Spain, United States, Austria
-
AmgenCompletedAcute Lymphoblastic LeukemiaGermany, United States, France, Australia, Spain, Italy, Netherlands, Austria, United Kingdom
-
Gilead SciencesThe Leukemia and Lymphoma SocietyActive, not recruitingNon Hodgkin LymphomaUnited States, Australia, United Kingdom
-
Dizal PharmaceuticalsCompletedRelapsed or Refractory Peripheral T Cell LymphomaKorea, Republic of, United States, China, Australia
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
Therapeutic Advances in Childhood Leukemia ConsortiumTakeda; Children's Hospital Los AngelesActive, not recruitingLymphoblastic Leukemia, Acute, Childhood | ALL, Childhood | Lymphoblastic Lymphoma, ChildhoodUnited States, Australia
-
National Cancer Institute (NCI)Active, not recruitingT Acute Lymphoblastic Leukemia | T Lymphoblastic LymphomaUnited States, Canada, Australia, New Zealand, Switzerland
-
Eisai Inc.Dr. Reddy's Laboratory; Citius PharmaceuticalsCompletedPersistent or Recurrent Cutaneous T-Cell LymphomaUnited States, Australia, Puerto Rico
-
Therapeutic Advances in Childhood Leukemia ConsortiumTerminatedAcute Lymphoblastic Leukemia | Precursor B-Cell Lymphoblastic Leukemia | Precursor T-Cell Lymphoblastic LeukemiaUnited States, Australia
-
The Lymphoma Academic Research OrganisationCelgeneActive, not recruitingRelapsed Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-cell LymphomaFrance, Denmark, United Kingdom, Austria, Belgium
-
Caribou Biosciences, Inc.RecruitingLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | B Cell Non-Hodgkin's LymphomaUnited States, Australia, Israel
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingMarginal Zone LymphomaItaly, Switzerland, Austria
-
Medical University of ViennaUnknownLymphoma, Mantle-CellAustria
-
Therapeutic Advances in Childhood Leukemia ConsortiumEnzon Pharmaceuticals, Inc.TerminatedLymphoblastic Leukemia, Acute, Childhood | Leukemia, Lymphoblastic, Acute | Lymphoblastic Leukemia, Acute | Leukemia, Lymphoblastic, Acute, T CellUnited States, Australia
-
Medical University of GrazUnknownLymphoproliferative Disorders | Psoriasis | Eczema | Pruritus | Vitiligo | Cutaneous T Cell Lymphoma | Mastocytosis | Graft Vs Host Disease | Lichen Planus | Prurigo | Polymorphic Light EruptionAustria
-
Hoffmann-La RocheRecruitingLymphoma, Non-HodgkinUnited States, Denmark, Italy, France, Australia, United Kingdom
-
PfizerCompletedNon-Hodgkin's LymphomaKorea, Republic of, Australia, Czechia, United States, Romania, Germany, France, Poland, Italy, Russian Federation, Serbia
-
Mundipharma Research LimitedTerminatedIndolent B-cell NHLAustralia, Slovakia
-
Hoffmann-La RocheActive, not recruitingNon-Hodgkin Lymphoma | B-Cell LymphomaUnited States, Italy, Canada, Australia, Spain, Denmark, France, Germany, United Kingdom
-
MedImmune LLCTerminatedB-Cell Pediatric ALLUnited States, Australia, France, Spain, Canada, Netherlands, United Kingdom, Italy
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada, Australia, Switzerland, Puerto Rico
-
AmgenCompletedB-Cell Non Hodgkin LymphomaUnited States, Spain, United Kingdom, Belgium, Italy, Australia, Canada, Puerto Rico
-
Pharmacyclics Switzerland GmbHJanssen Biotech, Inc., including Johnson & JohnsonEnrolling by invitationLymphoma, B-Cell | Lymphoma, Non-Hodgkin | Solid Tumor | Leukemia, B-cell | Graft Vs Host DiseaseUnited States, Spain, Taiwan, United Kingdom, Australia, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, France, Turkey, Czechia, Hungary, Poland, Sweden
-
Genentech, Inc.Active, not recruitingLymphocytic Leukemia, Chronic | Lymphoma, Non HodgkinUnited States, Korea, Republic of, Australia, United Kingdom, Germany, Canada, Spain
-
Kyowa Kirin, Inc.CompletedCutaneous T-Cell LymphomaUnited States, Spain, France, Australia, Switzerland, United Kingdom, Japan, Denmark, Germany, Italy, Netherlands
-
Eisai Inc.CompletedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary SyndromeGermany, Canada, United Kingdom, Austria, Russian Federation, United States, Australia, Poland, Switzerland, Netherlands